Corticosteroid-impairment of healing and gastric pentadecapeptide BPC-157 creams in burned mice

Burns

Volumn 29, Issue 4, 2003, Pages 323-334

  Sikiric, P ^a   Seiwerth, S ^a   Mise, S ^a   Staresinic, M ^a   Bedekovic, V ^a   Zarkovic, N ^a   Borovic, S ^a   Gjurasin, M ^a   Boban Blagaic, A ^a   Batelja, L ^a   Rucman, R ^a   Anic, T ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

BPC 157 (PL 10, PLO 116, PL 14736); Corticosteroid impairment; Gastric pentadecapeptide; Healing

Indexed keywords

ANTIULCER AGENT; CORTICOSTEROID; GLYCYLGLUTAMYLPROLYLPROLYLPROLYLGLYCYLLYSYLPROLYLALANYLASPARTYLASPARTYLALAN YLGLYCYLLEUCYLVALINE; GLYCYLGLUTAMYLPROLYLPROLYLPROLYLGLYCYLLYSYLPROLYLALANYLASPARTYLASPARTYLALANYLGLYCYLLEUCYLVALINE; METHYLPREDNISOLONE; NITROGEN; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTICLE; BURN; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; ENTEROPATHY; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; INFLAMMATION; MALE; MEDICAL ASSESSMENT; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; SPLEEN CELL; STOMACH LESION; WOUND HEALING IMPAIRMENT;

EID: 0037684727     PISSN: 03054179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0305-4179(03)00004-4     Document Type: Article

References (44)

1. Eubanks T.R., Greenberg J.J., Dobrin P.B., Harford F.J., Gamelli R.L. The effects of different corticosteroids on the healing colon anastomosis and cecum in a rat model. Am Surg. 63:1997;266-269.
2. Frank S., Madlener M., Pfeilschifter J., Werner S. Induction of inducible nitric oxide synthase and its corresponding tetrahydrobiopterin-cofactor synthesizing enzyme GTP-cyclohydrolase I during cutaneous wound repair. J. Invest. Dermatol. 111:1998;1058-1064.
3. Golan J., Mitelman S., Baruchin A., Ben-Hur N. Vitamin A and corticosteroid interaction in wound healing in rats. Israel J. Med. Sci. 16:1980;572-575.
4. Hatz R.A., Kelley S.F., Ehrlich H.P. The tetrachlorodecaoxygen complex reverses the effect of cortisone on wound healing. Plast. Rec. Surg. 84:1989;953-959.
5. Sikiric P., Seiwerth S., Grabarevic Z., Petek M., Rucman R., Turkovic B.et al. The beneficial effect of BPC-157, a 15 amino acid peptide BPC fragment, on gastric and duodenal lesions induced by restraint stress, cysteamine and 96% ethanol in rats. A comparative study with H2 receptor antagonists, dopamine promoters and gut peptides. Life Sci. 54:1994;PL63-PL68.
6. Sikiric P., Seiwerth S., Grabarevic Z., Rucman R., Petek M., Jagic V.et al. Pentadecapeptide BPC-157 positively affects both non-steroidal anti-inflammatory agent-induced gastrointestinal lesions and adjuvant arthritis in rats. J. Physiol. (Paris). 91:1997;113-122.
7. Sikiric P., Seiwerth S., Grabarevic Z., Rucman R., Petek M., Jagic V.et al. The influence of a novel pentadecapeptide BPC-157 on NG-nitro-L-arginine methyl ester and L-arginine effect on stomach mucosal integrity and blood pressure. European J. Pharmacol. 332:1997;23-33.
8. Sikiric P., Seiwerth S., Deskovic S., Grabarevic Z., Marovic A., Rucman R.et al. New model of cytoprotection/adaptive cytoprotection in rats: endogenous small irritants. European J. Pharmacol. 364:1999;23-31.
9. Bilic I., Zoricic I., Anic T., Separovic J., Stancic-Rokotov D., Mikus D. Haloperidol-stomach lesions attenuation by pentadecapeptide BPC-157, omeprazole, bromocriptine, but not atropine, lansoprazole, pantoprazole, ranitidine, cimetidine and misoprostol in mice. Life Sci. 68:2001;1905-1912.
10. Mikus D., Sikiric P., Seiwerth S., Petricevic A., Aralica G., Druzijanic N.et al. Pentadecapeptide BPC-157 cream improves burn-wound healing and attenuates burn-gastric lesions in mice. Burns. 127:2001;817-827.
11. Sandor Z., Vincze A., Szabo S. The protective effect of a recently isolated gastric peptide in acute and chronic gastroduodenal injury. FASEB J. 10:1996;171.
12. Sandor Z., Vincze A., Jadus M.R., Dohocky C., Erceg D., Brajsa K.et al. The protective effect of newly isolated peptide PL-10 in the iodoacetamide colitis in rats. Gastroenterology. 112:1997;400.
13. Paré W., Kluczynski J.M. The effect of new gastric juice peptide BPC on classic stress triad in stress procedure. Exp. Clin. Gastroenterol. 4:1994;234-236.
14. Sikiric P., Banic M., Brkic T., Seiwerth S., Grabarevic Z., Rucman R.et al. Effects of a novel pentadecapeptide BPC-157 and methylprednisolone in a murine model of inflammatory bowel disease. Gastroenterology. 104:1993;782.
15. Sikiric P., Seiwerth S., Aralica G., Perovic D., Staresinic M., Anic T.et al. Therapy effect of anti-ulcer agents on new chronic cysteamine colon lesion in rat. J. Physiol. (Paris). 95:2001;283-288.
16. Zoricic I, Sikiric P, Seiwerth S. Pentadecapeptide BPC-157 beneficially influences the healing of colon-colon anastomoses in rats. In: Mozsik G, Nagy L, Par A, Rainsford KD, editors. Cell injury and protection in the gastrointestinal tract. From basic sciences to clinical perspectives 1996. Dodrecht: Kluwer Academic Publishers; 1997. p. 249-58.
17. Prkacin I., Separovic J., Aralica G., Perovic D., Gjurasin M., Lovric-Bencic M.et al. Portal hypertension and liver lesions in chronically drinking rats prevented and reversed by stable gastric pentadecapeptide BPC-157 (PL-10, PLD-116), and propranolol, but not ranitidine. J. Physiol. (Paris). 95:2001;315-324.
18. Sikiric P., Jadrijevic S., Seiwerth S., Sosa T., Deskovic S., Perovic D.et al. Long-lasting cytoprotection after pentadecapeptide BPC-157, ranitidine, sucralfate or cholestyramine application in reflux oesophagitis in rats. J. Physiol. (Paris). 93:1999;467-477.
19. Sikiric P., Mazul B., Seiwerth S., Grabarevic Z., Rucman R., Petek M. Pentadecapeptide BPC-157 interactions with adrenergic and dopaminergic systems in mucosal protection in stress. Dig. Dis. Sci. 42:1997;661-671.
20. Veljaca M., Lesch C.A., Sanchez B., Low J., Guglietta A. Protection of BPC-15 on TNBS-induced colitis in rats: possible mechanisms of action. Gastroenterology. 108:1995;936.
21. Veljaca M., Lesch C.A., Pllana R., Sanchez B., Chan K., Guglietta A. BPC-15 reduces trinitrobenzene sulfonic acid-induced colonic damage in rats. J Pharmacol. Exp. Ther. 272:1994;417-422.
22. Seiwerth S., Sikiric P., Grabarevic Z., Zoricic I., Hanzevacki M., Ljubanovic D.et al. BPC-157 effect on healing. J. Physiol. (Paris). 91:1997;173-178.
23. Sebecic B., Nikolic V., Sikiric P., Seiwerth S., Sosa T., Patrlj L.et al. Osteogenic effect of a gastric pentadecapeptide BPC-157, on the healing of segmental bone defect in rabbits. A comparison with bone marrow and autologous cortical bone implantation. Bone. 24:1999;195-202.
24. Konjevoda P, Nasic M, Curkovic T, Sikiric P, Seiwerth S, Stambuk N. Effects of BPC-157 on the healing of corneal lesions. In: Ohno S, Aoki K, Usui M, Uchio E, editors. Uveitis today. Amsterdam: Elsevier; 1998. p. 311-4.
25. Kiyohara Y., Komada F., Iwakawa S., Hirai M., Fuwa T., Okumura K. Improvement in wound healing by epidermal growth factor (EGF) ointment. Part II. Effect of protease inhibitor, nafamostat, on stabilization and efficacy of EGF in burn. J. Pharmacobio-Dyn. 14:1991;47-52.
26. Mustoe T.A., Pierce G.F., Thomason A., Grmates P., Sporn M.B., Deuel T.F. Accelarated healing of incisional wounds in rats induced by transforming growth factor-β Science. 237:1987;1333-1336.
27. Urist M.R. The first three decades of bone morphogenetic protein. Osteologie. 4:1996;207-233.
28. Veljaca M., Chan K., Guglietta A. Digestion of h-EGF, h-TGF-α, and BPC-15 in human gastric juice. Gastroenterology. 108:1995;761.
29. Stambuk N., Konjevoda P. Computational determination of biologically active motifs of the bone morphogenetic protein precursors. Period Biol. 101:1999;363-368.
30. Sikiric P., Separovic J., Anic T., Buljat G., Mikus D., Seiwerth S.et al. The effect of pentadecapeptide BPC-157, H2-blockers, omeprazole and sucralfate on new vessels and new granulation tissue formation. J Physiol (Paris). 93:1999;479-485.
31. Pearson C.M. Development of arthritis, periarthritis and periostitis in rats given adjuvants. Proc. Soc. Exp. Biol. (NY). 91:1956;95-101.
32. Hernandez D.E. Neuroendocrine mechanisms of stress ulceration: focus on thyrotropin releasing hormone (TRH). Life Sci. 39:1986;279-296.
33. Hernandez D.E. Part I. Brain regulation of gut functions. The role of brain peptides in the pathogenesis of experimental stress gastric ulcers. Ann. N.Y. Acad. Sci. 597:1990;28-35.
34. Jelovac N., Sikiric P., Rucman R., Petek M., Marovic A., Perovic D.et al. Pentadecapeptide BPC-157 attenuates disturbances induced by neuroleptics: the effect on catalepsy and gastric ulcers in mice and rats. European J. Pharmacol. 379:1999;19-31.
35. Sikiric P., Petek M., Rucman R., Seiwerth S., Grabarevic Z., Rotkvic I.et al. A new gastric juice peptide BPC - an overview of stomach/stress/organoprotection hypothesis and BPC beneficial effects. J. Physiol. (Paris). 87:1993;313-327.
36. Cetinkale O., Demir M., Sayman H.B., Ayen F., Onsel C. Effects of allopurinol, ibuprofen and cyclosporin A on local microcirulatory disturbances due to burn injuries. Burns. 23:1997;43-49.
37. Wahl SM. Glucocorticoids and wound healing. In: Schleimer RP, Claman HN, Oronsky A, editors. Anti-inflammatory steroid action. Basic and clinical aspects. San Diego: Academic Press Inc.; 1992. p. 280-302.
38. Kovacs K., Yeghiayan E., Hatakeyama S., Selye H. Adrenocortical lipoid hyperplasia induced in rats by aniline. Experientia. 26:1970;1014-1015.
39. Ulland A.E., Shearer J.D., Coulter C., Caldwell M.D. Altered wound arginine metabolism by corticosterone and retinoic acid. J. Surg. Res. 70:1997;84-88.
40. Robert A., Nezamis J.E., Lancaster C., Badalamenti J.N. Cysteamine-induced duodenal ulcers: a new model to test ant-ulcer agents. Digestion. 11:1974;199-214.
41. Lallemant Y., Gehanno P., Guedon C. Preventive treatment in caustic stenosis of the oesophagus. Ann Oto-Laryngol. Chir Cervico-Faciale. 95:1978;367-372.
42. Szabo S. Critical and timely review of the concept of gastric cytoprotection. In: Mozsik G, Javor T, Kitajima M, Pheiffer CJ, Rainsford KD, Simon L, Szabo S, editors. Advances in gastrointestinal cytoprotection: Topics 1987. Budapest: Akademiai Kiado; 1989. p. 115-28.
43. Hamon G.A., Hunt T.K., Spencer E.M. In vivo effects of systemic insulin-like growth factor-I alone and complexed with insulin-like growth factor binding protein-3 on corticosteroid suppressed wounds. Growth Regulat. 3:1993;53-56.
44. Suh D.Y., Hunt T.K., Spencer E.M. Insulin-like growth factor-I reverses the impairment of wound healing induced by corticosteroids in rats. Endocrinology. 131:1992;2399-2403.